Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Diethyl cyanomethylphosphonate is a versatile chemical and medical intermediate, characterized as a clear colorless to light yellow liquid. It is widely recognized for its utility as a modified Wittig reagent in organic synthesis, particularly for the preparation of substituted nitriles, amides, and heterocyclic derivatives.

2537-48-6

Post Buying Request

2537-48-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2537-48-6 Usage

Uses

Used in Organic Synthesis:
Diethyl cyanomethylphosphonate serves as a key intermediate in the Horner-Emmons reaction, facilitating the synthesis of substituted nitriles and their amide and heterocyclic derivatives. It is particularly effective in the preparation of alpha, beta-unsaturated nitriles from ketones or aldehydes, such as 3-hydroxy-3-methylbutanal.
Used in the Preparation of Cyano-Substituted Compounds:
This intermediate is also utilized in the reaction with epoxides and nitrones, leading to the formation of cyano-substituted cyclopropanes and aziridines, respectively. These reactions contribute to the development of complex molecular structures with potential applications in various fields.
Used in the Synthesis of Alpha-arylated Alkanenitriles:
Diethyl cyanomethylphosphonate plays a crucial role in the synthesis of alpha-arylated alkanenitriles through its reaction with aryl iodides in the presence of CuI. This process is vital for the creation of novel compounds with potential applications in pharmaceuticals and materials science.
Used as a Raw Material for Nitrogen-Haloamine Precursors:
In the medical field, Diethyl cyanomethylphosphonate is used as a raw material to synthesize nitrogen-haloamine precursor AEP-ADCT, which contains a triazine-phosphate group. This precursor is essential for the development of new pharmaceutical agents with potential therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 2537-48-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,3 and 7 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2537-48:
(6*2)+(5*5)+(4*3)+(3*7)+(2*4)+(1*8)=86
86 % 10 = 6
So 2537-48-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H12NO3P/c1-3-9-11(8,6-5-7)10-4-2/h3-4,6H2,1-2H3

2537-48-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C1430)  Diethyl Cyanomethylphosphonate  >98.0%(GC)

  • 2537-48-6

  • 5g

  • 290.00CNY

  • Detail
  • TCI America

  • (C1430)  Diethyl Cyanomethylphosphonate  >98.0%(GC)

  • 2537-48-6

  • 25g

  • 760.00CNY

  • Detail
  • Alfa Aesar

  • (A10218)  Diethyl cyanomethylphosphonate, 98+%   

  • 2537-48-6

  • 25g

  • 953.0CNY

  • Detail
  • Alfa Aesar

  • (A10218)  Diethyl cyanomethylphosphonate, 98+%   

  • 2537-48-6

  • 100g

  • 3132.0CNY

  • Detail
  • Alfa Aesar

  • (A10218)  Diethyl cyanomethylphosphonate, 98+%   

  • 2537-48-6

  • 500g

  • 7153.0CNY

  • Detail
  • Aldrich

  • (D91705)  Diethylcyanomethylphosphonate  98%

  • 2537-48-6

  • D91705-10G

  • 751.14CNY

  • Detail
  • Aldrich

  • (D91705)  Diethylcyanomethylphosphonate  98%

  • 2537-48-6

  • D91705-50G

  • 2,750.67CNY

  • Detail

2537-48-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-diethoxyphosphorylacetonitrile

1.2 Other means of identification

Product number -
Other names Diethylphosphonoacetonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2537-48-6 SDS

2537-48-6Synthetic route

chloroacetonitrile
107-14-2

chloroacetonitrile

triethyl phosphite
122-52-1

triethyl phosphite

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

Conditions
ConditionsYield
at 150℃; for 4h;99%
at 150℃; for 2h;92%
for 3h; Arbusov reaction; Heating;85%
cyanomethyl bromide
590-17-0

cyanomethyl bromide

triethyl phosphite
122-52-1

triethyl phosphite

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

Conditions
ConditionsYield
for 0.0333333h; Michaelis-Arbuzov reaction; microwave irradiation;95%
diethyl chlorophosphate
814-49-3

diethyl chlorophosphate

acetonitrile
75-05-8

acetonitrile

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

Conditions
ConditionsYield
Stage #1: acetonitrile With lithium hexamethyldisilazane In tetrahydrofuran; hexane at -78℃; for 0.5h; Metallation;
Stage #2: diethyl chlorophosphate In tetrahydrofuran at -78 - 0℃; for 0.25h; Substitution;
Stage #3: With hydrogenchloride In tetrahydrofuran; hexane Hydrolysis; Further stages.;
88%
With lithium diisopropyl amide 1.) THF, -30 deg C, 0.5 h, 2.) -30 deg C, 5 h; Yield given. Multistep reaction;
With lithium diisopropyl amide 1.) THF, -80 deg C, 15 min, 2.) THF, from -80 deg C to 0 deg C, 1 h; Multistep reaction;
chloroacetonitrile
107-14-2

chloroacetonitrile

triethyl phosphite
122-52-1

triethyl phosphite

A

chloroethane
75-00-3

chloroethane

B

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

Conditions
ConditionsYield
at 140 - 180℃;A n/a
B 84.5%
methanol
67-56-1

methanol

diazo-cyanomethylphosphonic acid diethyl ester
59463-50-2

diazo-cyanomethylphosphonic acid diethyl ester

A

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

B

diethyl ((cyanomethoxy)methyl)phosphonate
59463-48-8

diethyl ((cyanomethoxy)methyl)phosphonate

Conditions
ConditionsYield
In water for 3h; Irradiation; Sealed tube; Cooling with ice;A 66%
B 11%
diethyl cyanomethylphosphonate potassium salt

diethyl cyanomethylphosphonate potassium salt

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

Conditions
ConditionsYield
With ethyl 4-nitrobenzoate In dimethyl sulfoxide at 24.9℃; Equilibrium constant;
1-cyano-1-(diethoxyphosphoryl)-2-[(6-methylpyrid-2-yl)amino]-2-(trifluoromethyl)ethylene

1-cyano-1-(diethoxyphosphoryl)-2-[(6-methylpyrid-2-yl)amino]-2-(trifluoromethyl)ethylene

A

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

B

2,2,2-trifluoro-N-(6-methyl-2-pyridinyl)acetamide
334711-70-5

2,2,2-trifluoro-N-(6-methyl-2-pyridinyl)acetamide

Conditions
ConditionsYield
With air
2,3-dichloroquinoxaline
2213-63-0

2,3-dichloroquinoxaline

(2-amino-2-thioxoethyl)phosphonic acid diethyl ester
77679-10-8

(2-amino-2-thioxoethyl)phosphonic acid diethyl ester

A

2-chloro-3-[(3-chloro-2-quinoxalinyl)-thio]quinoxaline
1062508-50-2

2-chloro-3-[(3-chloro-2-quinoxalinyl)-thio]quinoxaline

B

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

furfural
98-01-1

furfural

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

(E)-3-(2-furyl)acrylonitrile
6125-63-9

(E)-3-(2-furyl)acrylonitrile

Conditions
ConditionsYield
With water; barium dihydroxide In 1,4-dioxane at 70℃; for 0.666667h;100%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
Stage #2: furfural In tetrahydrofuran at 28℃;
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5h;
Stage #2: furfural In tetrahydrofuran; mineral oil at 0 - 25℃; for 2h;
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

7-Methoxy-1-tetralone
6836-19-7

7-Methoxy-1-tetralone

(7-methoxy-3,4-dihydro-2H-naphthalene-1-ylidene)acetonitrile
127299-26-7

(7-methoxy-3,4-dihydro-2H-naphthalene-1-ylidene)acetonitrile

Conditions
ConditionsYield
With sodium methylate In methanol at -20 - -10℃; for 24h; Reagent/catalyst; Wittig Rearrangement;100%
Stage #1: diethyl 1-cyanomethylphosphonate With potassium hydroxide In dimethyl sulfoxide at 15 - 25℃; for 1h; Industry scale;
Stage #2: 7-Methoxy-1-tetralone In tetrahydrofuran; dimethyl sulfoxide at 15 - 25℃; for 2.5h; Product distribution / selectivity;
95%
Stage #1: 7-Methoxy-1-tetralone With sodium hydride In 1,2-dimethoxyethane at 15℃; for 0.5h;
Stage #2: diethyl 1-cyanomethylphosphonate In monoethylene glycol diethyl ether at 10 - 15℃;
89%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

benzaldehyde
100-52-7

benzaldehyde

cinnamic nitrile
1885-38-7

cinnamic nitrile

Conditions
ConditionsYield
With caesium carbonate at 20℃; for 24h; Horner reaction;100%
With sodium hydride 1.) THF, RT, 20 min, 2.) THF, RT, 72 h; Multistep reaction;
In tetrahydrofuran at 0℃; for 3h; Yield given;
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

4-(cyanomethylidene)piperidine-1-carboxylic acid tert-butyl ester

4-(cyanomethylidene)piperidine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran at -70℃; for 0.666667h; Inert atmosphere;100%
With lithium hexamethyldisilazane In tetrahydrofuran at -70℃; for 0.666667h; Inert atmosphere;100%
With lithium bromide In tetrahydrofuran at 20℃; for 3h; Inert atmosphere;100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

(4E,6E)-5-Methyl-7-(2,6,6-trimethyl-cyclohex-1-enyl)-hepta-4,6-dienal
219130-11-7

(4E,6E)-5-Methyl-7-(2,6,6-trimethyl-cyclohex-1-enyl)-hepta-4,6-dienal

(2E,6E,8E)-7-Methyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,6,8-trienenitrile

(2E,6E,8E)-7-Methyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,6,8-trienenitrile

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

1-naphthaldehyde
66-77-3

1-naphthaldehyde

3-(1-naphthyl)acrylonitrile
111686-30-7

3-(1-naphthyl)acrylonitrile

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 20℃; Wadsworth-Emmons reaction;100%
With potassium carbonate for 0.25h; Ambient temperature;
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

3,3'-difluorobenzophenone
345-70-0

3,3'-difluorobenzophenone

3,3'-bis(3-fluorophenyl)acrylonitrile
170019-08-6

3,3'-bis(3-fluorophenyl)acrylonitrile

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide100%
With sodium hydride In N,N-dimethyl-formamide Horner-Emmons coupling;100%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 0.416667h;
Stage #2: 3,3'-difluorobenzophenone In tetrahydrofuran; mineral oil at 80℃; Cooling with ice;
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

N-(4-methoxybenzylidene)-p-toluenesulfonamide
14674-38-5

N-(4-methoxybenzylidene)-p-toluenesulfonamide

diethyl [(E)-1-cyano-2-(4-methoxyphenyl)ethenyl]phosphonate
36315-64-7

diethyl [(E)-1-cyano-2-(4-methoxyphenyl)ethenyl]phosphonate

Conditions
ConditionsYield
With dimethyl sulfoxide at 20℃; for 1h; Knoevenagel condensation; Inert atmosphere; Molecular sieve; optical yield given as %de; stereoselective reaction;100%
With potassium tert-butylate In tetrahydrofuran at 20℃; for 0.0333333h; Condensation;81%
Stage #1: diethyl 1-cyanomethylphosphonate With potassium tert-butylate In dimethyl sulfoxide Knoevenagel type condensation;
Stage #2: N-(4-methoxybenzylidene)-p-toluenesulfonamide In dimethyl sulfoxide at 20℃; Kinetics;
3-methoxy-4-(phenylmethoxy)benzaldehyde
2426-87-1

3-methoxy-4-(phenylmethoxy)benzaldehyde

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

4-benzyloxy-3-methoxy-β-cyanostyrene

4-benzyloxy-3-methoxy-β-cyanostyrene

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 0℃; for 1.5h;100%
4-methyl-pent-3-en-2-one
141-79-7

4-methyl-pent-3-en-2-one

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

3,5-Dimethyl-2,4-hexadienenitrile
54354-52-8

3,5-Dimethyl-2,4-hexadienenitrile

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran; hexane at -60 - 20℃;100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

3,5-dimethoxybenzaldehdye
7311-34-4

3,5-dimethoxybenzaldehdye

3-(3,5-dimethoxyphenyl)acrylonitrile
153507-02-9

3-(3,5-dimethoxyphenyl)acrylonitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 20℃; for 0.25h;
Stage #2: 3,5-dimethoxybenzaldehdye In tetrahydrofuran at 20℃; for 17h;
100%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
Stage #2: 3,5-dimethoxybenzaldehdye In tetrahydrofuran at 28℃;
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

1-[(1-methylcyclopropyl)sulfonyl]azetidin-3-one
1187594-26-8

1-[(1-methylcyclopropyl)sulfonyl]azetidin-3-one

2-(1-((1-methylcyclopropyl)sulfonyl)azetidin-3-ylidene)acetonitrile
1187594-27-9

2-(1-((1-methylcyclopropyl)sulfonyl)azetidin-3-ylidene)acetonitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃;
Stage #2: 1-[(1-methylcyclopropyl)sulfonyl]azetidin-3-one In tetrahydrofuran; mineral oil at 20℃; for 16h;
100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

5,5-dichloro-4-oxo-1-(p-toluenesulfonyl)-4,5,6,7,-tetrahydroindole

5,5-dichloro-4-oxo-1-(p-toluenesulfonyl)-4,5,6,7,-tetrahydroindole

2-(5,5-dichloro-6,7-dihydro-1-tosyl-1H-indol-4(5H)-ylidene)acetonitrile
1236306-10-7

2-(5,5-dichloro-6,7-dihydro-1-tosyl-1H-indol-4(5H)-ylidene)acetonitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 0.5h; Inert atmosphere;
Stage #2: 5,5-dichloro-4-oxo-1-(p-toluenesulfonyl)-4,5,6,7,-tetrahydroindole In tetrahydrofuran; mineral oil at 0 - 20℃; Inert atmosphere;
100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

tert-butyl 3-formylpyrrolidine-1-carboxylate
59379-02-1

tert-butyl 3-formylpyrrolidine-1-carboxylate

tert-butyl 3-[(E)-2-cyanoethenyl]pyrrolidine-1-carboxylate

tert-butyl 3-[(E)-2-cyanoethenyl]pyrrolidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With potassium tert-butylate In tetrahydrofuran at 0 - 20℃; for 2h;
Stage #2: tert-butyl 3-formylpyrrolidine-1-carboxylate In tetrahydrofuran at 0 - 20℃; for 16h;
100%
With potassium tert-butylate In tetrahydrofuran at 0 - 20℃; for 12h;86.1%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

2-cyclopentylacetaldehyde
5623-81-4

2-cyclopentylacetaldehyde

4-cyclopentylbut-2-enenitrile
1269823-36-0

4-cyclopentylbut-2-enenitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 1h;
Stage #2: 2-cyclopentylacetaldehyde In tetrahydrofuran; mineral oil at 20℃;
100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

4-N,N-di-n-butylamino-2-methoxybenzaldehyde
103893-16-9

4-N,N-di-n-butylamino-2-methoxybenzaldehyde

3-(4-dibutylamino-2-methoxyphenyl)acrylonitrile
1267604-90-9

3-(4-dibutylamino-2-methoxyphenyl)acrylonitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran for 0.416667h; Cooling with ice;
Stage #2: 4-N,N-di-n-butylamino-2-methoxybenzaldehyde In tetrahydrofuran for 1h;
100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

C12H16N2O

C12H16N2O

C14H17N3

C14H17N3

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With potassium tert-butylate In tetrahydrofuran at 5 - 20℃; for 1h; Inert atmosphere;
Stage #2: C12H16N2O In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

lithium ethyl cyanomethylphosphonate

lithium ethyl cyanomethylphosphonate

Conditions
ConditionsYield
With lithium bromide at 100℃; for 70h;100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

7-diethylamino-9,9-dimethylfluorene-2-carbaldehyde
1208005-62-2

7-diethylamino-9,9-dimethylfluorene-2-carbaldehyde

(E)-3-(7-(diethylamino)-9,9-dimethyl-9H-fluoren-2-yl)acrylonitrile

(E)-3-(7-(diethylamino)-9,9-dimethyl-9H-fluoren-2-yl)acrylonitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: 7-diethylamino-9,9-dimethylfluorene-2-carbaldehyde In tetrahydrofuran at 20℃; for 4h;
100%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5h;
Stage #2: 7-diethylamino-9,9-dimethylfluorene-2-carbaldehyde In tetrahydrofuran; mineral oil at 20℃; for 4h;
100%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

C19H34O4Si

C19H34O4Si

C21H35NO3Si

C21H35NO3Si

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With n-butyllithium In tetrahydrofuran; hexane at 0℃; for 1h;
Stage #2: C19H34O4Si In tetrahydrofuran; hexane at 0 - 20℃; Wittig-Horner Reaction;
100%
cyclohexanedione monoethylene ketal
4746-97-8

cyclohexanedione monoethylene ketal

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

2-<4,4-(ethylenedioxy)cyclohexylidene>acetonitrile
124499-35-0

2-<4,4-(ethylenedioxy)cyclohexylidene>acetonitrile

Conditions
ConditionsYield
With 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone; sodium hydride In tetrahydrofuran; paraffin for 12h;99%
Stage #1: diethyl 1-cyanomethylphosphonate With 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone; sodium hydride In tetrahydrofuran for 0.416667h; Inert atmosphere;
Stage #2: cyclohexanedione monoethylene ketal at 20℃; for 3h;
96%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran
Stage #2: cyclohexanedione monoethylene ketal With 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone In tetrahydrofuran
95%
2-(1,3-dithian-2-yl)-2-methylpropanal
64872-91-9

2-(1,3-dithian-2-yl)-2-methylpropanal

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

(E)-4-(1,3-dithian-2-yl)-4-methylpent-2-enenitrile
139745-78-1

(E)-4-(1,3-dithian-2-yl)-4-methylpent-2-enenitrile

Conditions
ConditionsYield
With lithium diisopropyl amide In tetrahydrofuran99%
With lithium diisopropyl amide In tetrahydrofuran; hexane 1.) -78 deg C, 45 min; 2.) -78 deg C, 2 h; RT, 2 h;99%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

6,6'-dideuterio-3,3'-dimethylbenzophenone
144617-64-1

6,6'-dideuterio-3,3'-dimethylbenzophenone

C17H13(2)H2N
144617-69-6

C17H13(2)H2N

Conditions
ConditionsYield
With sodium hydride In 1,2-dimethoxyethane99%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

cyclopentanone
120-92-3

cyclopentanone

cyclopentylideneacetonitrile
5732-88-7

cyclopentylideneacetonitrile

Conditions
ConditionsYield
With sodium hydride In diethyl ether at 20℃; Cooling with ice;99%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In N,N-dimethyl-formamide at 0℃;
Stage #2: cyclopentanone In N,N-dimethyl-formamide at 0 - 20℃;
89%
With potassium carbonate In water at 80℃; for 2.5h;88%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

3-tetrahydropyran-2-yloxy-androst-5-en-17-one
19637-35-5

3-tetrahydropyran-2-yloxy-androst-5-en-17-one

20-carbonitrilopregna-5,17(20)diene 3β-tetrahydropyranyl ether

20-carbonitrilopregna-5,17(20)diene 3β-tetrahydropyranyl ether

Conditions
ConditionsYield
With sodium hydride Wittig-Horner reaction;99%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In 1,2-dimethoxyethane for 0.166667h; Heating;
Stage #2: 3-tetrahydropyran-2-yloxy-androst-5-en-17-one In 1,2-dimethoxyethane for 5h; Wittig-Horner reaction; Heating; Further stages.;
99%
5-Norbornene-2-carboxaldehyde
5453-80-5, 19926-90-0

5-Norbornene-2-carboxaldehyde

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

(E)-3-Bicyclo[2.2.1]hept-5-en-2-yl-acrylonitrile

(E)-3-Bicyclo[2.2.1]hept-5-en-2-yl-acrylonitrile

Conditions
ConditionsYield
With polymer-anchored quaternary trimethylammonium hydroxide In acetonitrile at 20℃; for 1h; Horner-Emmons olefination;99%
tert-butyl 3-oxoazetidine-1-carboxylate
398489-26-4

tert-butyl 3-oxoazetidine-1-carboxylate

diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

3-(cyanomethylene)azetidine-1-carboxylic acid tert-butyl ester
1153949-11-1

3-(cyanomethylene)azetidine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃;
Stage #2: tert-butyl 3-oxoazetidine-1-carboxylate In tetrahydrofuran; mineral oil Product distribution / selectivity;
99%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 0 - 20℃;
Stage #2: tert-butyl 3-oxoazetidine-1-carboxylate In tetrahydrofuran at 0℃;
Stage #3: With water In tetrahydrofuran
98%
Stage #1: diethyl 1-cyanomethylphosphonate With potassium tert-butylate In tetrahydrofuran at 0 - 30℃;
Stage #2: tert-butyl 3-oxoazetidine-1-carboxylate In tetrahydrofuran at 0 - 30℃;
95%
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

3-benzyloxy cyclobutanone
30830-27-4

3-benzyloxy cyclobutanone

2-(3-(benzyloxy)cyclobutylidene)acetonitrile
1187595-82-9

2-(3-(benzyloxy)cyclobutylidene)acetonitrile

Conditions
ConditionsYield
Stage #1: diethyl 1-cyanomethylphosphonate With triethylamine; lithium bromide In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
Stage #2: 3-benzyloxy cyclobutanone at 20℃; for 20h; Concentration;
99%
Stage #1: diethyl 1-cyanomethylphosphonate With triethylamine; lithium bromide In tetrahydrofuran at 10℃; for 1.5h; Inert atmosphere;
Stage #2: 3-benzyloxy cyclobutanone In tetrahydrofuran at 10℃; for 20h; Inert atmosphere;
91%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1h; Inert atmosphere;
Stage #2: 3-benzyloxy cyclobutanone In tetrahydrofuran at 20℃;
80%
Stage #1: diethyl 1-cyanomethylphosphonate With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1h; Inert atmosphere;
Stage #2: 3-benzyloxy cyclobutanone In tetrahydrofuran at 20℃; Inert atmosphere;
80%
Stage #1: diethyl 1-cyanomethylphosphonate With potassium tert-butylate In tetrahydrofuran at 0 - 20℃;
Stage #2: 3-benzyloxy cyclobutanone In tetrahydrofuran at 0 - 20℃;
diethyl 1-cyanomethylphosphonate
2537-48-6

diethyl 1-cyanomethylphosphonate

4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

2-Nitrobenzenesulfonyl chloride
1694-92-4

2-Nitrobenzenesulfonyl chloride

(E)-β-[4-(2-nitrobenzenesulfonyloxy)phenyl]acrylonitrile

(E)-β-[4-(2-nitrobenzenesulfonyloxy)phenyl]acrylonitrile

Conditions
ConditionsYield
Stage #1: 4-hydroxy-benzaldehyde; 2-Nitrobenzenesulfonyl chloride With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 1.5h;
Stage #2: diethyl 1-cyanomethylphosphonate With lithium chloride at 20℃; for 24h; Inert atmosphere;
99%

2537-48-6Relevant articles and documents

One-step Synthesis of Stabilized Phosphonates

Kandil, Ali A.,Porter, Terence M.,Slessor, Keith N.

, p. 411 - 413 (1987)

Phosphonates possessing α-electron withdrawing functionalities can be readily prepared by treatment of nitriles, nitroalkanes, and esters with 2 molar equivalents of base followed by phosphonylation with diethyl chlorophosphate.

Carbanionic displacement reactions at phosphorus. Part III.1 Cyanomethylphosphonate vs. cyanomethylenediphosphonate. Synthesis and solid-state structures

Lorga, Bogdan,Ricard, Louis,Savignac, Philippe

, p. 3311 - 3316 (2000)

The results of the carbanionic reaction between acetonitrile and chlorophosphates depend strongly on the nature of the metallating agent (LiTMP, LDA, LiHMDS). According to the nature of the base, the reaction can be directed towards the formation of either cyanomethylphosphonates 3 or cyanomethylenediphosphonates 5. Electrophilic halogenation of lithiated cyanomethylphosphonate 2a leads to the mono-chloro 17, -bromo 18 and -iodo 19 derivatives. Only the monochloro product 17 is stable enough to be isolated in pure form. The structures of cyanobenzylphosphonate 10b, cyanomethylenediphosphonate 5b and its corresponding lithiated carbanion 4b are determined by X-ray crystallography. The polymeric structure, coupled with a wide charge delocalization, without C-Li contacts, is in agreement with the lack of reactivity towards electrophiles. The Royal Society of Chemistry 2000.

Photocatalytic Alkylation of Pyrroles and Indoles with α-Diazo Esters

Ciszewski, Lukasz W.,Durka, Jakub,Gryko, Dorota

supporting information, p. 7028 - 7032 (2019/09/12)

This article describes the photoalkylation of electron-rich aromatic compounds with diazo esters. C-2-alkylated indoles and pyrroles are obtained with good yields even though the photocatalyst loading is as low as 0.075 mol %. For EWG-substituted substrates, the addition of a catalytic amount of N,N-dimethyl-4-methoxyaniline is required. Both EWG-EWG- and EWG-EDG-substituted diazo esters are suitable as alkylating agents. The reaction selectivity and mechanistic experiments suggest that carbenes/carbenoid intermediates are not involved in the reaction pathway.

Truncated borrelidin analogues: Synthesis by sequential cross metathesis/olefination for the southern fragment and biological evaluation

Gündemir-Durmaz, Tülay,Schmid, Fabian,El Baz, Yana,H?usser, Annette,Schneider, Carmen,Bilitewski, Ursula,Rauhut, Guntram,Garnier, Delphine,Baro, Angelika,Laschat, Sabine

supporting information, p. 8261 - 8269 (2016/09/09)

The construction of novel borrelidin analogues is reported in which the northern fragment is truncated to a simple hydroxyundecanecarboxylate and the original cyclopentanecarboxylic acid in the southern fragment is replaced with different six-membered rings. The required precursors were prepared by cross metathesis of the appropriate carbocycle-based homoallylic alcohol with crotonaldehyde followed by HWE olefination of the resulting enal with bromocyanophosphonate. The key aldehyde for intramolecular cross coupling was accessible by oxidation of the hydroxy group of the linked undecanecarboxylate unit. Grignard mediated macrocyclization finally yielded the borrelidin related products. The investigation is complemented by SAR studies and quantum-chemical calculations.

Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation

Wu, Ming-Yu,Esteban, Gerard,Brogi, Simone,Shionoya, Masahi,Wang, Li,Campiani, Giuseppe,Unzeta, Mercedes,Inokuchi, Tsutomu,Butini, Stefania,Marco-Contelles, Jose

, p. 864 - 879 (2016/08/18)

Currently available drugs against Alzheimer's disease (AD) are only able to ameliorate the disease symptoms resulting in a moderate improvement in memory and cognitive function without any efficacy in preventing and inhibiting the progression of the pathology. In an effort to obtain disease-modifying anti-Alzheimer's drugs (DMAADs) following the multifactorial nature of AD, we have recently developed multifunctional compounds. We herein describe the design, synthesis, molecular modeling and biological evaluation of a new series of donepezil-related compounds possessing metal chelating properties, and being capable of targeting different enzymatic systems related to AD (cholinesterases, ChEs, and monoamine oxidase A, MAO-A). Among this set of analogues compound 5f showed excellent ChEs inhibition potency and a selective MAO-A inhibition (vs MAO-B) coupled to strong complexing properties for zinc and copper ions, both known to be involved in the progression of AD. Moreover, 5f?exhibited moderate antioxidant properties as found by in?vitro assessment. This compound represents a novel donepezil–hydroxyquinoline hybrid with DMAAD profile paving the way to the development of a novel class of drugs potentially able to treat AD.

Design, synthesis and SAR study of novel sulfonylureas containing an alkenyl moiety

Wei, Wei,Cheng, Dandan,Liu, Jingbo,Li, Yuxin,Ma, Yi,Li, Yonghong,Yu, Shujing,Zhang, Xiao,Li, Zhengming

, p. 8356 - 8366 (2016/09/09)

A series of sulfonylurea compounds was designed and synthesized via introducing an alkenyl moiety into the aryl-5 position and most title compounds exhibited enhanced antifungal activities and limited herbicidal activities compared with chlorsulfuron. Then, a CoMSIA calculation for antifungal activities was carried out to establish a 3D-QSAR model in which a cross-validated q2 of 0.585 and a correlation coefficient r2 of 0.989 were obtained. The derived model revealed that hydrophobic and electrostatic fields were the two most important factors for antifungal activity. Structure optimization was performed according to the CoMSIA model and compound 9z was found to be as potent as chlorothalonil in vitro against C. cornigerum, the pathogen of the wheat sharp eyespot disease. In order to study the fungicidal mechanism, 9z was successfully docked into yeast AHAS using a flexible molecular docking method and the resulting binding pattern was similar to that of chlorimuron-ethyl, indicating that the antifungal activity of compounds 9 was probably due to the inhibition of fungal AHAS.

Multi-target-oriented protective agent neurocyte

-

Paragraph 0118; 0119; 0120, (2017/03/28)

PROBLEM TO BE SOLVED: To provide a promising multi target direction type pharmaceutical candidate molecule which is promising for treatments of Alzheimer-type dementia (AD), which is a molecule having good cell membrane permeability including blood brain barrier.SOLUTION: A compound designed by a conjunction method with which a benzylpiperidine part of an acetylcholine esterase (AChE) inhibitor, donepezil is connected through an oligomethylene linker and combined with a propargyl part having a monoamine oxidase(MAO) inhibition activity and 8-hydroxy-5-methylaminoquinoline functional group, i.e. a center nitrogen atom substituted by a pro-chelator motif of a biochemical metal, interacts with AChE and butyrylcholinesterase(BuChE), further MAOA and B.

Simple synthesis of new 3-substituted 4-(3-chloro-4-fluorophenyl)-1h- pyrrole derivatives and their anticancer activity in vitro

Lan, Lan,Zhan, Xiaoping,Qin, Weixi,Liu, Zenglu,Maoa, Zhenmin

, p. 375 - 397 (2014/03/21)

The preparation of the new 3-substituted 4-(3-chloro-4-fluorophenyl)- 1H-pyrrole derivatives was based on the Van Leusen pyrrole synthesis. In this article, eighteen compounds were readily synthesized in satisfactory to good yields and their cell proliferation inhibiting activities against 2 normal cell lines and 16 cancer cell lines were evaluated. It was particularly important that the new pyrroles displayed barely cytotoxicity against the tested normal cell, which meant these pyrrole analogues might show excellent selectivity towards cancer cell and normal cell. Cell cycle analysis by flow cytometry (FCM) showed that the G0/G1 phase decreased a lot and S phase arrested, in between a minor and transient G2/M block was observed. Cell death induced by 3-cyano-4-(3-chloro-4- fluorophenyl)-1H-pyrrole (2r) was also verified by multiple methods.

Neuroprotective multi-target directed drugs

-

Paragraph 0101, (2014/05/20)

A new family of multitarget molecules able to interact with acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), as well as with monoamino oxidase (MAO) A and B, has been synthesized. Novel compounds have been designed using a conjunctive approach that combines the benzylpiperidine moiety of the AChE inhibitor donepezil, connected through an oligomethylene linker, to a central nitrogen atom substituted with the propargyl moiety responsible for the MAO inhibition, and a 8-hydroxy-5-methylaminoquinoline functional group, the biometal pro-chelator motif. Overall, the results suggest that the new compounds are promising multitarget drug candidates with potencial impact for AD therapy.

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

Wang, Li,Esteban, Gerard,Ojima, Masaki,Bautista-Aguilera, Oscar M.,Inokuchi, Tsutomu,Moraleda, Ignacio,Iriepa, Isabel,Samadi, Abdelouahid,Youdim, Moussa B.H.,Romero, Alejandro,Soriano, Elena,Herrero, Raquel,Fernández Fernández, Ana Patricia,Ricardo-Martínez-Murillo,Marco-Contelles, José,Unzeta, Mercedes

, p. 543 - 561 (2014/06/09)

The synthesis, biochemical evaluation, ADMET, toxicity and molecular modeling of novel multi-target-directed Donepezil + Propargylamine + 8-Hydroxyquinoline (DPH) hybrids 1-7 for the potential prevention and treatment of Alzheimer's disease is described. The most interesting derivative was racemic α-aminotrile4-(1-benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-5-yl) methyl)(prop-2-yn-1-yl)amino) butanenitrile (DPH6) [MAO A (IC50 = 6.2 ± 0.7 μM; MAO B (IC50 = 10.2 ± 0.9 μM); AChE (IC50 = 1.8 ± 0.1 μM); BuChE (IC50 = 1.6 ± 0.25 μM)], an irreversible MAO A/B inhibitor and mixed-type AChE inhibitor with metal-chelating properties. According to docking studies, both DPH6 enantiomers interact simultaneously with the catalytic and peripheral site of EeAChE through a linker of appropriate length, supporting the observed mixed-type AChE inhibition. Both enantiomers exhibited a relatively similar position of both hydroxyquinoline and benzyl moieties with the rest of the molecule easily accommodated in the relatively large cavity of MAO A. For MAO B, the quinoline system was hosted at the cavity entrance whereas for MAO A this system occupied the substrate cavity. In this disposition the quinoline moiety interacted directly with the FAD aromatic ring. Very similar binding affinity values were also observed for both enantiomers with ChE and MAO enzymes. DPH derivatives exhibited moderate to good ADMET properties and brain penetration capacity for CNS activity. DPH6 was less toxic than donepezil at high concentrations; while at low concentrations both displayed a similar cell viability profile. Finally, in a passive avoidance task, the antiamnesic effect of DPH6 was tested on mice with experimentally induced amnesia. DPH6 was capable to significantly decrease scopolamine-induced learning deficits in healthy adult mice.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2537-48-6